Replies to post #135035 on Biotech Values

[dav1234]

INHX initiated as buy nov 3,by DB,then all hell broke loose,lol

Also unusually high vol started 10-17-11

[BTH]

This is a great great read.

Thanks for posting this.

[BTH]

The takeaway to this is that there is at least one other major pharma out there actively seeking an HCV asset to acquire, or to acquire an entire company.

Really interesting read.

[DewDiligence]

During the period December 1, 2011 through January 3, 2012, [BMY’s] representatives and representatives of Citi and Kirkland & Ellis LLP, [BMY’s] legal counsel, conducted detailed business, financial, scientific, technical, regulatory, environmental, intellectual property and legal due diligence investigations of [INHX] and its business and operations…

Environmental?

[DewDiligence]

BMS-094 (f/k/a INX-189, a/k/a BMS-986094) is in trouble, according to Nathan Sadeghi-Nejad:

http://www.thestreet.com/story/11523381/1/bristol-myers-missing-hep-c-data-raises-red-flags-may-boost-gilead-idenix.html

Comments from anyone? (My most recent post on this drug is in #msg-72304518, FWIW.)